Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)